GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shine-On BioMedical Co Ltd (ROCO:6926) » Definitions » Other Income (Expense)

Shine-On BioMedical Co (ROCO:6926) Other Income (Expense) : NT$1.27 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Shine-On BioMedical Co Other Income (Expense)?

Shine-On BioMedical Co's other income expense for the Shine-On BioMedical Co's pretax income for the six months ended in Dec. 2024 was NT$0.98 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2024 was NT$1.27 Mil.


Shine-On BioMedical Co Other Income (Expense) Historical Data

The historical data trend for Shine-On BioMedical Co's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shine-On BioMedical Co Other Income (Expense) Chart

Shine-On BioMedical Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Income (Expense)
Get a 7-Day Free Trial - - -11.37 7.70 1.27

Shine-On BioMedical Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only -11.37 3.96 3.74 0.29 0.98

Shine-On BioMedical Co Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$1.27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shine-On BioMedical Co  (ROCO:6926) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


Shine-On BioMedical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 633, Section 2, Taiwan Avenue, Unit 6, 5th Floor, Xitun District, Taichung, TWN
Shine-On BioMedical Co Ltd develops drugs based on antibodies and nucleic acids. The Company researches, develops, manufactures, and distributes antibody anticancer drugs, nucleic acid anticancer drugs. The company's drug development and nucleic acid therapeutics are focused on providing patients with the most effective cancer treatment options.

Shine-On BioMedical Co Headlines

No Headlines